Name: |
PHENYTOIN (DilantinR) |
Classification: |
anticonvulsant; antiarrhythmic
- treatment or prophylaxis of tonic-clonic seizures
- management of status epilepticus
- treatment of ventricular tachycardia and paroxysmal tachycardia especially secondary to digoxin toxicity
|
Dose: |
- Loading Dose:
- Maintenance Dose:
- 5mg/kg/day (in divided doses every 8 hours)
|
Administration: |
- IV Direct:
- preferred route of administration; rate not to exceed 50mg/min
- IV Infusion:
- must be mixed in sodium chloride 0.9% or Ringer's Lactate; do not mix with dextrose solutions as precipitation will occcur
- concentration of 1-20mg/ml; rate not to exceed 50mg/min
- must be administered with a filter; a TPN set can be used and changed with the same frequency of other line changes
- administer at slower rate if patient is receiving dopamine or in the presence of cardiovascular instability
- IV line to be flushed with NS or RL before and after phenytoin administration
- use prepared solutions immediately
|
Adverse Effects: |
- hypotension
- decreased automaticity of ventricles in second and complete AV heart block (suppression of ventricular escape rhythm)
- hyperglycemia
- nystagmus
- folic acid deficiency; megaloblastic anaemia
- nausea
- seizures (abrupt withdrawal may precipitate peripheral neuropathy seizure)
- rash
- lymphadenopathy
- gingival hyperplasia
|
Drug Interactions: |
- phenytoin + dopamine = increased hypotension
- phenytoin + theophylline = decreased theophylline effect
- phenytoin + dexamethasone = decreased dexamethasone effect
- phenytoin + quinidine = decreased quinidine effect
- phenytoin + amiodarone = increased phenytoin level
- phenytoin + fluconazole = increased phenytoin level
|
Monitoring Therapy: |
- BP
- HR and rhythm
- seizure activity
- neurological signs
- phenytoin levels: therapeutic 40 - 80 uM/L (pre-dose), toxic > 80 uM/L (need to adjust for low serum albumin and/or high urea levels, which will increase the free fraction of phenytoin leading to an increased amount of drug available for activity)
- draw levels immediately before next scheduled dose, or at least 4-6 hours post administration
|
Adult Critical Care Protocol: |
- May be administered by IV infusion and titrated by a nurse in Adult Critical Care
- May be administered IV direct by a nurse in Adult Critical Care provided that the rate does not exceed 50 mg/min
-
|